Trilaciclib for preventing myelosuppression caused by chemotherapy for extensive-stage small-cell lung cancer [ID6651]

  • In development
  • GID-TA11863
  • Expected publication date: TBC
Please note the appraisal is due to start in mid-May 2026. Submissions are expected in mid-July 2026.